PharmaResearch Co., Ltd.(KR:214450)
â‚©258,500.00+7500.00 (+2.99%)
KR:214450
PharmaResearch Co., Ltd. stock analysis
â‚©258,500.00
At close:+7500.00 (+2.99%)
PharmaResearch Co., Ltd. (214450) Stock Price & Analysis
214450 Stock Chart & Stats
â‚©258,500.00â‚©7,500.00(2.99%)
At close: Nov 16 3:30 PM GMT+9
- Day’s Range
- KRW 245,500.00 - KRW 264,000.00
- 52-Week Range
- KRW 208,000.00 - KRW 561,000.00
- Previous Close
- KRW 251,000.00
- Volume
- N/A
- Average Volume (3M)
- 94.83K
- Market Cap
- KRW 2.61T
- Enterprise Value
- KRW 3.33T
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 15.6
- Beta
- 0.17
- Next Earnings
- Mar 12, 2027 (Est.)
- EPS Estimate
- 3,357.97
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.47%
PharmaResearch Co., Ltd. News
214450 FAQ
What was PharmaResearch Co., Ltd.’s price range in the past 12 months?
PharmaResearch Co., Ltd. lowest stock price was â‚©208000.00 and its highest was â‚©561000.00 in the past 12 months.
What is PharmaResearch Co., Ltd.’s market cap?
PharmaResearch Co., Ltd.’s market cap is ₩2.61T.
When is PharmaResearch Co., Ltd.’s upcoming earnings report date?
PharmaResearch Co., Ltd.’s next earnings report is estimated for Mar 12, 2027 (not yet confirmed), which is in 115 days.
How were PharmaResearch Co., Ltd.’s earnings last quarter?
PharmaResearch Co., Ltd. released its earnings results on Nov 13, 2026. The company reported â‚©3,355.05 earnings per share for the quarter.
Is PharmaResearch Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PharmaResearch Co., Ltd. pay dividends?
PharmaResearch Co., Ltd. does not currently pay dividends.
What is PharmaResearch Co., Ltd.’s EPS estimate?
PharmaResearch Co., Ltd.’s EPS estimate is 3357.97.
How many shares outstanding does PharmaResearch Co., Ltd. have?
PharmaResearch Co., Ltd. has 10,389,648 shares outstanding.
What happened to PharmaResearch Co., Ltd.’s price movement after its last earnings report?
PharmaResearch Co., Ltd. reported an EPS of â‚©3,355.05 in its last earnings report. Following the earnings report the stock price went up 1.414%.
Which hedge fund is a major shareholder of PharmaResearch Co., Ltd.?
Currently, no hedge funds are holding shares in KR:214450
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
PharmaResearch Co., Ltd. (214450) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 4 | 10 |
| Technical Analysis | 2 | 4 | 4 |
| Moving Averages | 6 | 0 | 6 |



